The Centre for Rare Diseases at the Queen Elizabeth Hospital Birmingham offers a unique care hub to the patients it serves. Opened in September 2015, it has since seen around 2,000 patient appointments, with thirty four bespoke clinics integrating expert, multi-specialty care with research. The facility forms part of the NIHR Clinical Research Facility within the Institute of Translational Medicine.
The rare disease centre’s focus is on highly organised, one-stop clinics where patients, supported by their carers, undergo pre-planned diagnostic tests and see all the relevant specialists and the multi-disciplinary team in one visit. Working alongside the centre, the West Midlands Genomics Medicine Centre (WMGMC) is one of thirteen such centres in England delivering the 100,000 Genomes Project.
The WMGMC project complements the work within the rare disease centre and ensures the Trust is leading the way in improving the prediction and prevention of disease, enabling more new and precise diagnostic tests and allowing personalisation of drugs and other treatments to specific genetic variants to benefit generations to come.
Dr Graham Lipkin, Consultant Nephrologist and lead for the centre, said: “Many people in the UK are living with a rare disease, which can have a major impact on the quality of their life and on their close relatives. There are an estimated 7000 rare diseases and most of these are inherited. The centre works with our patients, staff and partners to coordinate input from the large number of medical, nursing and therapy specialists that are generally required to provide the best level of care for people living with these conditions.”
echtel, a global engineering, construction and project management firm, has opened a new office in Greater Birmingham that will act […]Read More
One of the world’s largest banking and financial services organisations, HSBC, has chosen Birmingham as the location for the head […]Read More
Global manufacturer Guhring, set up its new UK HQ in Birmingham following £12million worth of investment. The German-owned company chose […]Read More
Falanx Cyber Defence protect and defend businesses against cyber security threats. Partnering with its clients, the company uses its expertise, […]Read More
Edge Testing Solutions is creating 60 new jobs in Birmingham over the next two years following the launch of its […]Read More
Established in the Greater Birmingham region in 1972, East End Foods Plc has grown into one of the UK’s leading […]Read More
Cadbury became part of the Mondelez International family in 2010 and two years later a new global research and development […]Read More
Lombard Risk is a global fintech company, and is a leading provider of regulatory reporting and collateral management solutions. The […]Read More
The West Midlands Academic Health Science Network (WMAHSN) drives collaboration and productivity between academia, industry, healthcare providers and […]Read More
The Queen Elizabeth Hospital Birmingham (QEHB) is run by University Hospitals Birmingham NHS Foundation Trust (UHB), and is […]Read More
Research Park Ltd (BRPL) is nestled amongst a vibrant life science community including one of the UK’s […]Read More
For 30 years, Binding Site has specialised in delivering innovative medical solutions that improve the diagnosis and management […]Read More